← Back to Search

Procedure

Minimally Invasive vs Open Microdiscectomy for Herniated Disc

N/A

Waitlist Available

Led By Michael Johnson, MD

Research Sponsored by University of Manitoba

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Subjects will be between the ages of 18 and 90

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up continuous for 3 weeks postoperatively

Awards & highlights

Study Summary

This trial will compare two methods of surgery for lumbar herniated disc in terms of pain and functional status, using subjective and objective measures.

Who is the study for?

This trial is for men and women aged 18-90 with a CT-confirmed single level lumbar herniated disc, experiencing more leg than low back pain. They must speak/read English. Excluded are those with cauda equina syndrome, progressive neurological issues, bilateral leg symptoms, more back than leg pain, significant other illnesses or physical limitations.Check my eligibility

What is being tested?

The study compares minimally invasive microdiscectomy (MD) to conventional open discectomy (OD) for treating lumbar herniated discs. Participants will be randomly assigned to either MD or OD groups in equal chances and assessed pre- and post-surgery on pain/function using various subjective/objective measures.See study design

What are the potential side effects?

While the information provided does not specify side effects, generally microdiscectomy can cause discomfort at the incision site, nerve root damage, bleeding, infection or recurrence of disc herniation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 90 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ continuous for 3 weeks postoperatively

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~continuous for 3 weeks postoperatively

This trial's timeline: 3 weeks for screening, Varies for treatment, and continuous for 3 weeks postoperatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Physical activity monitor

Trial Design

2Treatment groups

Active Control

Group I: Minimally Invasive MicrodiscectomyActive Control1 Intervention

Group II: Conventional Open MicrodiscectomyActive Control1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor

595 Previous Clinical Trials

199,472 Total Patients Enrolled

Michael Johnson, MDPrincipal InvestigatorUniversity of Manitoba

2 Previous Clinical Trials

50 Total Patients Enrolled

Media Library

Microdiscectomy (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT00927056 — N/A

Herniated Disc or Slipped Disc Research Study Groups: Minimally Invasive Microdiscectomy, Conventional Open Microdiscectomy

Herniated Disc or Slipped Disc Clinical Trial 2023: Microdiscectomy Highlights & Side Effects. Trial Name: NCT00927056 — N/A

Microdiscectomy (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00927056 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can new subjects still join this clinical trial?

"This particular trial, as shown on clinicaltrials.gov, is not currently looking for new recruits. The trial was originally posted on 6/1/2009 and was last edited on 8/13/2011. Although this trial isn't taking any new participants right now, there are 51 other trials that are."

Answered by AI